CLINICAL_TRIALS
trial_result
· 2014-06-19
Clinical Trial Update: 24-hour IOP-lowering Effect of 0.01% Bimatoprost [Phase 4]
Summary
A Phase 4 clinical trial reports that 0.01% bimatoprost lowers intraocular pressure over a 24-hour period. The study results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Intraocular Pressure, Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2014-06-19